Non-penetrating glaucoma surgery augmented with mitomycin C or 5-fluorouracil in eyes at high risk of failure of filtration surgery: Long-term results

Clinical and Experimental Ophthalmology

Volumn 35, Issue 4, 2007, Pages 340-347

  Choudhary, Anshoo ^a   Wishart, Peter K ^a  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Deep sclerectomy; Filtration failure; Non penetrating glaucoma surgery; Uveitic glaucoma; Viscocanalostomy

Indexed keywords

CARBONATE DEHYDRATASE INHIBITOR; FLUOROURACIL; MITOMYCIN C; ALKYLATING AGENT; MITOMYCIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DRUG USE; DRUG WITHDRAWAL; FEMALE; FILTERING OPERATION; FOLLOW UP; GLAUCOMA; GLAUCOMA SURGERY; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTRAOCULAR PRESSURE; LONG TERM CARE; MALE; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; SCLERECTOMY; TRABECULECTOMY; TREATMENT FAILURE; TREATMENT RESPONSE; UVEITIS; DRUG EFFECT; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OCULOPLETHYSMOGRAPHY; OPEN ANGLE GLAUCOMA; PROSPECTIVE STUDY; TRABECULAR MESHWORK; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; ALKYLATING AGENTS; COMBINED MODALITY THERAPY; FEMALE; FILTERING SURGERY; FLUOROURACIL; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; MITOMYCIN; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SCLEROSTOMY; TONOMETRY, OCULAR; TRABECULAR MESHWORK; TREATMENT FAILURE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 34447650812     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2007.01483.x     Document Type: Article

References (48)

1. Agarwal HC, Sharma TK, Sihota R, Gulati V. Cumulative effect of risk factors on short-term surgical success of mitomycin augmented trabeculectomy. J Postgrad Med 2002; 48: 92-6.
2. Addicks EM, Quigley HA, Green WR, Robin AL. Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol 1983; 101: 795-8.
3. Skuta GL, Parrish RK. Wound healing in glaucoma filtering surgery. Surv Ophthalmol 1987; 32: 149-70.
4. Akarsu C, Onol M, Hasanreisoglu B. Postoperative 5-fluorouracil versus intraoperative mitomycin C in high-risk glaucoma filtering surgery: extended follow up. Clin Experiment Ophthalmol 2003; 31: 199-205.
5. Prata JA Jr, Neves RA, Minckler DS, Mermoud A, Heuer DK. Trabeculectomy with mitomycin C in glaucoma associated with uveitis. Ophthalmic Surg 1994; 25: 616-20.
6. Ceballos EM, Beck AD, Lynn MJ. Trabeculectomy with antiproliferative agents in uveitic glaucoma. J Glaucoma 2002; 11: 189-96.
7. Towler HM, McCluskey P, Shaer B, Lightman S. Long-term follow-up of trabeculectomy with intraoperative 5-fluorouracil for uveitis-related glaucoma. Ophthalmology 2000; 107: 1822-8.
8. The Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the fluorouracil filtering surgery study. Am J Ophthalmol 1996; 121: 349-66.
9. Cheung JC, Wright MM, Murali S, Pederson JE. Intermediate-term outcome of variable dose mitomycin C filtering surgery. Ophthalmology 1997; 104: 143-9.
10. Perkins TW, Gangnon R, Ladd W, Kaufman PL, Heatley GA. Trabeculectomy with mitomycin C: Intermediate-term results. J Glaucoma 1998; 7: 230-6.
11. Casson R, Rahman R, Salmon JF. Long term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure. Br J Ophthalmol 2001; 85: 686-8.
12. Fontana H, Nouri-Mahdavi K, Caprioli J. Trabeculectomy with mitomycin C in pseudophakic patients with open-angle glaucoma: Outcomes and risk factors for failure. Am J Ophthalmol 2006; 141: 652-9.
13. Anand N, Arora S, Clowes M. Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. Br J Ophthalmol 2006; 90: 175-80.
14. Belyea DA, Dan JA, Stamper RL, Lieberman MF, Spencer WH. Late onset of sequential multifocal bleb leaks after glaucoma filtration surgery with 5-fluorouracil and mitomycin C. Am J Ophthalmol 1997; 124: 40-5.
15. Bindlish R, Condon GP, Schlosser JD, D'Antonio J, Lauer KB, Lehrer R. Efficacy and safety of mitomycin-C in primary trabeculectomy: Five-year follow-up. Ophthalmology 2002; 109: 1336-41.
16. Mietz H, Krieglstein GK. Three-year follow-up of trabeculectomies performed with different concentrations of mitomycin-C. Ophthalmic Surg Lasers 1998; 29: 628-34.
17. Solomon A, Ticho U, Frucht-Pery J. Late-onset, bleb-associated endophthalmitis following glaucoma filtering surgery with or without antifibrotic agents. J Ocul Pharmacol Ther 1999; 15: 283-93.
18. DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol 2002; 120: 297-300.
19. Karlen ME, Sanchez E, Schnyder CC, Sickenberg M, Mermoud A. Deep sclerectomy with collagen implant: Medium term results. Br J Ophthalmol 1999; 83: 6-11.
20. Khairy HA, Green FD, Nassar MK, Azuara-Blanco. Control of intraocular pressure after deep sclerectomy. Eye 2005; 20: 336-40.
21. Mermoud A, Schnyder CC, Sickenberg M, Chiou AG, Hediguer SE, Faggioni R. Comparison of deep sclerectomy with collagen implant and trabeculectomy in open-angle glaucoma. J Cataract Refract Surg 1999; 25: 323-31.
22. Shaarawy T, Mansouri K, Schnyder C, Ravinet E, Achache F, Mermoud A. Long-term results of deep sclerectomy with collagen implant. J Cataract Refract Surg 2004; 30: 1225-31.
23. Wishart PK, Wishart MS, Porooshani H. Viscocanalostomy and deep sclerectomy for the surgical treatment of glaucoma: A longterm follow-up. Acta Ophthalmol Scand 2003; 81: 343-8.
24. Shaarawy T, Nguyen C, Schnyder C, Mermoud A. Five year results of viscocanalostomy. Br J Ophthalmol 2003; 87: 441-5.
25. Chiou AG, Mermoud A, Jewelewicz DA. Post-operative inflammation following deep sclerectomy with collagen implant versus standard trabeculectomy. Graefes Arch Clin Exp Ophthalmol 1998; 236: 593-6.
26. Stegmann R, Pienaar A, Miller D. Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg 1999; 25: 316-22.
27. Sunaric-Megevand G, Leuenberger PM. Results of viscocanalostomy for primary open-angle glaucoma. Am J Ophthalmol 2001; 132: 221-8.
28. Shaarawy T, Karlen M, Schnyder C, Achache F, Sanchez E, Mermoud A. Five-year results of deep sclerectomy with collagen implant. J Cataract Refract Surg 2001; 27: 1770-8.
29. Rothman RF, Liebmann JM, Ritch R. Low-dose 5-fluorouracil trabeculectomy as initial surgery in uncomplicated glaucoma: Long-term followup. Ophthalmology 2000; 107: 1184-90.
30. Liebmann JM, Ritch R. Bleb related ocular infection: A feature of the HELP syndrome. Hypotony, endophthalmitis, leak, pain. Br J Ophthalmol 2000; 84: 1338-9.
31. Franks W. Trypan blue staining of antiproliferative agents for trabeculectomy surgery and bleb needling. Br J Ophthalmol 2005; 89: 1394-5.
32. Singh K, Mehta K, Shaikh NM etal. Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial. Ophthalmology 2000; 107: 2305-9.
33. Sturmer J, Broadway DC, Hitchings RA. Young patient trabeculectomy. Assessment of risk factors for failure. Ophthalmology 1993; 100: 928-39.
34. Joseph JP, Grierson I, Hitchings RA. Chemotactic activity of aqueous humor. A cause of failure of trabeculectomies? Arch Ophthalmol 1989; 107: 69-74.
35. Netland PA. Nonpenetrating glaucoma surgery. Ophthalmology 2001; 108: 416-21.
36. Miserocchi E, Carassa RG, Bettin P, Brancato R. Viscocanalostomy in patients with glaucoma secondary to uveitis: Preliminary report. J Cataract Refract Surg 2004; 30: 566-70.
37. Souissi K, El Afrit MA, Trojet S, Kraiem A. [Deep sclerectomy for the management of uveitic glaucoma.] J Fr Ophtalmol 2006; 29: 265-8 (in French).
38. Anand N, Atherley C. Deep sclerectomy augmented with mitomycin C. Eye 2005; 19: 442-50.
39. Auer C, Mermoud A, Herbort CP. Deep sclerectomy for the management of uncontrolled uveitic glaucoma: Preliminary data. Klin Monatsbl Augenheilkd 2004; 221: 339-42.
40. Neudorfer M, Sadetzki S, Anisimova S, Geyer O. Nonpenetrating deep sclerectomy with the use of adjunctive mitomycin C. Ophthalmic Surg Lasers Imaging 2004; 35: 6-12.
41. Rebolleda G, Munoz-Negrete FJ. Deep sclerectomy with mitomycin C in failed trabeculectomy. Eye 2005; 21: 23-8.
42. Jampel HD. Effect of brief exposure to mitomycin C on viability and proliferation of cultured human Tenon's capsule fibroblasts. Ophthalmology 1992; 99: 1471-6.
43. Yaldo MK, Stamper RL. Long-term effects of mitomycin on filtering blebs. Lack of fibrovascular proliferative response following severe inflammation. Arch Ophthalmol 1993; 111: 824-6.
44. Mietz H. The toxicology of mitomycin C on the ciliary body. Curr Opin Ophthalmol 1996; 7: 72-9.
45. Agarwal HC, Saigal D, Sihota R. Assessing the role of subconjunctival versus intrascleral application of mitomycin C in high-risk trabeculectomies. Indian J Ophthalmol 2001; 49: 91-5.
46. Rebolleda G, Munoz-Negrete FJ. Deep sclerectomy with mitomycin C in failed trabeculectomy. Eye 2007; 21: 23-8.
47. Chaudhry IA, Pasha MA, O'Connor DJ, Weitzman ML, Caprioli J. Randomized, controlled study of low-dose 5-fluorouracil in primary trabeculectomy. Am J Ophthalmol 2000; 130: 700-3.
48. Budenz DL, Hoffman K, Zacchei A. Glaucoma filtering bleb dysesthesia. Am J Ophthalmol 2001; 131: 626-30.